Clinical Trial Update: Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles [Phase 4]

View source ↗

Summary

Phase 4 trial comparing patient preference for subcutaneous versus vaginal progesterone as luteal support in IVF/ICSI cycles, terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In Vitro Fertilization
• Infertility

Snippet

Sponsor: Andros Day Surgery Clinic | Conditions: Infertility, In Vitro Fertilization | Phase 4 | Status: TERMINATED